Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
180 institutional managers report a position in Esperion Therapeutics, Inc. worth $645.3M between them, filed on form 13F for the quarter ending 2026-06-30. 28 of them hold 80% of it, the largest being Glazer Capital, LLC at 10.98%.
155 more managers in the register
28 managers hold 80% of the $645.3M institutional base. The other 152 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
ESPR (Esperion Therapeutics, Inc.) has 1 disclosed suppliers and 6 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: PFE −0.67%, in healthcare.
Esperion Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 3.19 · opened flat. High/low 3.20 at 6:15 pm ET, 3.19 at 9:30 am ET.
via Glazer Capital, LLC, Gabelli Funds LLC, Gabelli Securities, Inc. +6 more · 10.98% of ESPR, 10.82% of ALOT
via Glazer Capital, LLC, CNH Partners LLC, Gabelli Securities, Inc. +4 more · 10.98% of ESPR, 9.62% of GIW
via Glazer Capital, LLC, Oddo BHF Asset Management SAS, Highland Capital Management Fund Advisors, L.P. +9 more · 10.98% of ESPR, 3.87% of CCRN
via Balyasny Asset Management LLC, CNH Partners LLC, Highland Capital Management Fund Advisors, L.P. +15 more · 2.28% of ESPR, 5.14% of TALK
via Glazer Capital, LLC, CNH Partners LLC, TIG Advisors, LLC +3 more · 10.98% of ESPR, 8.78% of AXIN
via CNH Partners LLC, Balyasny Asset Management LLC, Highland Capital Management Fund Advisors, L.P. +13 more · 2.96% of ESPR, 2.72% of AVNS
Managers holding a meaningful stake in ESPR also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.